Skip to main content Skip to main navigation menu Skip to site footer
  • Home
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Current
  • Anteriores
  • Notícias
Search
  • Register
  • Login
  1. Home /
  2. Archives - Page 3

Archives - Page 3

  • Vol. 18 No. 3/4 (2006)

  • Vol. 18 No. 1/2 (2006)

  • Vol. 17 No. 7/9 (2005)

  • Vol. 17 No. 5/6 (2005)

  • Vol. 17 No. 3/4 (2005)

  • Vol. 16 No. 13/14 (2005)

  • Vol. 16 No. 11/12 (2004)

  • Vol. 16 No. 9/10 (2004)

  • Vol. 16 No. 7/8 (2004)

  • Vol. 16 No. 5/6 (2004)

  • Vol. 16 No. 3/4 (2004)

  • Vol. 16 No. 1/2 (2004)

  • Vol. 15 No. 11/12 (2003)

  • Vol. 15 No. 9/10 (2003)

  • Vol. 15 No. 7/8 (2003)

  • Vol. 15 No. 4/6 (2003)

  • Vol. 15 No. 1/3 (2003)

  • Vol. 14 No. 11/12 (2002)

  • Vol. 14 No. 9/10 (2002)

  • Vol. 14 No. 7/8 (2002)

  • Vol. 14 No. 5/6 (2002)

  • Vol. 15 No. 3/4 (2002)

  • Vol. 14 No. 1/2 (2002)

  • Vol. 13 No. 11/12 (2001)

  • Vol. 13 No. 9/10 (2001)

  • Vol. 14 No. 7/8 (2001)

  • Vol. 14 No. 5/6 (2001)

  • Vol. 13 No. 3/4 (2001)

  • Vol. 13 No. 1/2 (2001)

  • Vol. 12 No. 11/12 (2000)

  • Vol. 12 No. 9/10 (2000)

  • Vol. 12 No. 7/8 (2000)

  • Vol. 12 No. 5/6 (2000)

  • Vol. 13 No. 1/2 (2000)

  • Vol. 12 No. 1/1 (2000)

  • Vol. 11 No. 11/12 (1999)

  • Vol. 11 No. 9/10 (1999)

  • Vol. 10 No. 1/6 (1999)

  • Vol. 9 No. 1/5 (1999)

  • Vol. 7 No. 1/4 (1999)

  • Vol. 7 No. 1/2 (1998)

  • Vol. 6 No. 3/4 (1997)

  • Vol. 6 No. 1/2 (1997)

  • Vol. 5 No. 1/4 (1996)

  • Vol. 4 No. 1/6 (1995)

Previous 91-135 of 145 Next

Make a Submission

Make a Submission

Language

  • English
  • Português (Brasil)

Keywords

Most Read in the last 30 days
  • SUBSTÂNCIAS ATIVAS UTILIZADAS EM PRODUTOS ANTICASPA
    700
  • HEMOFILIAS: FISIOPATOLOGIA, DIAGNÓSTICO E TRATAMENTO
    689
  • ANÁLISE E DISCUSSÃO DE ASPECTOS CRÍTICOS DA RESOLUÇÃO 67/2007 DA ANVISA PARA AS FARMÁCIAS COM MANIPULAÇÃO
    626
  • AVANÇOS NAS DIRETRIZES DE BOAS PRÁTICAS DE FABRICAÇÃO DE PRODUTOS FARMACÊUTICOS ESTÉREIS
    534
  • DERMATITE SEBORRÉICA: CAUSAS, DIAGNÓSTICO E TRATAMENTO
    521

Information

  • For Readers
  • For Authors
  • For Librarians

Developed By

Open Journal Systems

Infarma, Brasília, Distrito Federal, Brasil, e-ISSN: 2318-9312

More information about the publishing system, Platform and Workflow by OJS/PKP.